Home>Topics>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International VRX

  1. All
  2. Commentary
  3. Headlines
    1. Ultimate Stock-Pickers: Top Holdings of Top-Performing Managers

      Headlines

      Tue, 16 Dec 2014

      benchmark index). Allergan AGN "> AGN , which has been the subject of a takeover battle, with Valeant Pharmaceuticals VRX "> VRX on one side with a $180 per share bid and Actavis ACT "> ACT on the other side with a $219 per share offer, has been

    2. Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock

      Headlines

      Tue, 9 Dec 2014

      NEW YORK/WINNIPEG (Reuters) - Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and

    3. For David Krempa - VRX

      Commentary

      Mon, 1 Dec 2014

      Do you expect to prepare an analyst note anytime soon on Valeant’s prospects following the abortive Allergan deal?

    4. CORRECTED-Valeant slashes stake in Allergan after losing bid

      Headlines

      Fri, 21 Nov 2014

      Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent, three days after Actavis Plc trumped its offer for the Botox maker.

    5. Valeant slashes stake in Allergan after losing bid

      Headlines

      Thu, 20 Nov 2014

      Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker.

    6. UPDATE 1-Valeant Pharma says may buy back up to $2 bln worth of securities

      Headlines

      Thu, 20 Nov 2014

      Nov 20 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion worth of securities, replacing a previous $1.5 billion program under which it bought back no securities.

    7. Valeant Pharma may buy back up to $2 bln worth of securities

      Headlines

      Thu, 20 Nov 2014

      Nov 20 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion in senior notes, shares and other securities.

    8. Allergan agrees to $66 billion Actavis offer; Valeant walks

      Headlines

      Mon, 17 Nov 2014

      (Reuters) - Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc, ending a seven-month hostile pursuit by activist investor William Ackman and Valeant Pharmaceuticals International Inc.

    9. UPDATE 4-Allergan agrees to $66 bln Actavis offer; Valeant walks

      Headlines

      Mon, 17 Nov 2014

      Nov 17 (Reuters) - Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc , ending a seven-month hostile pursuit by activist investor William Ackman and Valeant Pharmaceuticals International Inc.

    10. Losing Allergan deals blow to Valeant reputation

      Headlines

      Mon, 17 Nov 2014

      WINNIPEG/NEW YORK Nov 17 (Reuters) - The failure of Valeant Pharmaceuticals International Inc to buy Allergan Inc leaves it with nothing to show for a seven-month, bruising pursuit.

    « Prev12345Next »
    Content Partners